×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Myeloma
Feature Video
Dr Noopur Raje opens this program with a brief discussion on the basics of multiple myeloma. She describes what the disease is, highlights key risk factors, and explains how she helps educate her patients on their diagnosis. Cynthia Harrington discusses her role as a nurse practitioner when working with multiple myeloma patients and why a team-based approach between healthcare providers and the patient is important.
Katie Kosko
A 16-member team, including five patients with multiple myeloma, hiked through Iceland to raise money for disease research in hopes of finding a cure.
HEATHER STRINGER
Injectable forms of medication may benefit patients with blood cancers.
Brielle Urciuoli
Previously, there were concerns that older patients would not be able to handle the toxicities of the procedure, or that their stem cells, which are older, would not work as well. But that proved to not be the case.
Jason M. Broderick
The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Empliciti (elotuzumab) for use in combination with Pomalyst (pomalidomide) and low-dose dexamethasone (EPd) for the treatment of patients with relapsed/refractory multiple myeloma following two or more prior therapies, including Revlimid (lenalidomide) and a proteasome inhibitor (PI).
CURE Readers
See what CURE readers have to say about our previous issues.
Kristie L. Kahl
In this week’s episode of CURE Talks Cancer, we spoke with Ethan Hawes about his experience as a 22-year-old diagnosed with multiple myeloma, and his advice for others going through a similar journey.
Brielle Urciuoli
A patient's bone health history may offer clues into their myeloma outcomes, according to a recent study.
Brielle Urciuoli
Understanding these outcomes is important in planning treatments and mitigating the possibility of patients stopping their treatment.
Felicia Mitchell
Creating a medical family tree is helpful. If cancer is common, noting which branches include it can help inform decisions.